Works matching IS 01676997 AND DT 2008 AND VI 26 AND IP 6

Results: 9

Modulation of key signal transduction molecules by a novel peptide combination effective for the treatment of gastrointestinal carcinomas.
Published in:
Investigational New Drugs, 2008, v. 26, n. 6, p. 505, doi. 10.1007/s10637-008-9119-2
By:
- Singh, Anu;
- Jaggi, Manu;
- Prasad, Sudhanand;
- Dutt, Sarjana;
- Singh, Gurvinder;
- Datta, Kakali;
- Rajendran, Praveen;
- Sanna, Vinod;
- Mukherjee, Rama;
- Burman, Anand
Publication type:
Article
Anticancer activity of a peptide combination in gastrointestinal cancers targeting multiple neuropeptide receptors.
Published in:
Investigational New Drugs, 2008, v. 26, n. 6, p. 489, doi. 10.1007/s10637-008-9117-4
By:
- Jaggi, Manu;
- Prasad, Sudhanand;
- Singh, Anu;
- Praveen, R.;
- Dutt, Sarjana;
- Mathur, Archana;
- Sharma, Rajan;
- Gupta, Neena;
- Ahuja, Rinku;
- Mukherjee, Rama;
- Burman, Anand
Publication type:
Article
Optimal modeling for phase I design of a two drug combination—results of a phase I study of cisplatin with 9-nitrocamptothecin.
Published in:
Investigational New Drugs, 2008, v. 26, n. 6, p. 541, doi. 10.1007/s10637-008-9147-y
By:
- Lee, S.-J.;
- Gounder, M.;
- Rubin, E.;
- Li, Jong;
- Gu, Zheming;
- Thalasila, A.;
- Loyer, E.;
- Kudelka, A.;
- Verschraegen, C.
Publication type:
Article
Phase Ι trial of weekly Docetaxel and daily Temozolomide in patients with metastatic disease.
Published in:
Investigational New Drugs, 2008, v. 26, n. 6, p. 553, doi. 10.1007/s10637-008-9153-0
By:
- Tamaskar, I.;
- Mekhail, T.;
- Dreicer, R.;
- Olencki, T.;
- Roman, S.;
- Elson, P.;
- Bukowski, R.
Publication type:
Article
Effect of oral administration of kefir on serum proinflammatory cytokines on 5-FU induced oral mucositis in patients with colorectal cancer.
Published in:
Investigational New Drugs, 2008, v. 26, n. 6, p. 567, doi. 10.1007/s10637-008-9171-y
By:
- Topuz, E.;
- Derin, D.;
- Can, G.;
- Kürklü, E.;
- Çınar, S.;
- Aykan, F.;
- Çevikbaş, A.;
- Dişçi, R.;
- Durna, Z.;
- Şakar, B.;
- Saglam, S.;
- Tanyeri, H.;
- Deniz, G.;
- Gürer, Ü.;
- Taş, F.;
- Guney, N.;
- Aydıner, A.
Publication type:
Article
Evaluation of the therapeutic efficacy of tripeptide tyroserleutide (YSL) for human hepatocarcinoma by in vivo hollow fiber assay.
Published in:
Investigational New Drugs, 2008, v. 26, n. 6, p. 525, doi. 10.1007/s10637-008-9121-8
By:
- Li, Xiao-lei;
- Liu, Jun-yan;
- Lu, Rong;
- Xu, Qiong;
- Zhu, Zhi-feng;
- Wang, Li;
- Zhou, Chun-lei;
- Jia, Jing;
- Fu, Zheng;
- Yao, Zhi
Publication type:
Article
CPT21, a novel compound with anti-proliferative effect against gastric cancer cell SGC7901.
Published in:
Investigational New Drugs, 2008, v. 26, n. 6, p. 517, doi. 10.1007/s10637-008-9120-9
By:
- Zhang, Bo;
- Luo, Yu;
- Weng, Qinjie;
- He, Qiaojun;
- Lu, Wei;
- Yang, Bo
Publication type:
Article
Aberrant crypt foci and AgNORs as putative biomarkers to evaluate the chemopreventive efficacy of pronyl-lysine in rat colon carcinogenesis.
Published in:
Investigational New Drugs, 2008, v. 26, n. 6, p. 531, doi. 10.1007/s10637-008-9122-7
By:
- Panneer Selvam, Jayabal;
- Aranganathan, Selvaraj;
- Nalini, Namasivayam
Publication type:
Article
O-Mel-Inib: A Cancéro-pôle Nord-Ouest multicenter phase II trial of high-dose Imatinib mesylate in metastatic uveal melanoma.
Published in:
Investigational New Drugs, 2008, v. 26, n. 6, p. 561, doi. 10.1007/s10637-008-9143-2
By:
- Penel, Nicolas;
- Delcambre, Corinne;
- Durando, Xavier;
- Clisant, Stéphanie;
- Hebbar, Mohamed;
- Negrier, Sylvie;
- Fournier, Charles;
- Isambert, Nicolas;
- Mascarelli, Frédéric;
- Mouriaux, Frédéric
Publication type:
Article